Phenothiazinium derivatives for pathogen inactivation in blood products

Journal of Photochemistry and Photobiology B: Biology

Volumn 86, Issue 1, 2007, Pages 45-58

  Wainwright, Mark ^a   Mohr, Harald ^b   Walker, Wolfram H ^c  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b Institute Springe   (Germany)

^c MacoPharma International GmbH   (Germany)

Author keywords

Benzo a phenothiazinium; Blood products; Pathogen inactivation; Phenothiazinium; Plasma; Platelets; Red blood cells

Indexed keywords

METHYLENE BLUE; PHENOTHIAZINE DERIVATIVE; PHENOTHIAZINIUM DERIVATIVE; PHOTOSENSITIZING AGENT; THIONINE; THROMBOCYTE CONCENTRATE; TOLONIUM CHLORIDE;

BLOOD STAIN; CHROMATOPHORE; CYTOLOGY; CYTOPATHOLOGY; DISINFECTION; HEMOLYSIS; HUMAN; LEUKOCYTE ACTIVATION; MICROBIAL CONTAMINATION; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; REVIEW; SAFETY; ULTRAVIOLET RADIATION;

BLOOD; BLOOD-BORNE PATHOGENS; HUMANS; MICROBIAL VIABILITY; PHENOTHIAZINES; PHOTOSENSITIZING AGENTS;

EID: 33751539836     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2006.07.005     Document Type: Review

References (80)

1. Zeina B., Greenman J., Purcell W.M., and Das B. Killing of cutaneous microbial species by photodynamic therapy. Br. J. Dermatol. 144 (2001) 274-278
2. DeEds F. Antiseptic value of phenothiazines in urinary tract infections. J. Pharmacol. 65 (1939) 353-371
3. DeWitt L.M. Preliminary report of experiments in the vital staining of tubercles. J. Infect. Dis. 12 (1913) 68-92
4. Wainwright M., and Crossley K.B. Methylene Blue - a therapeutic dye for all seasons?. J. Chemother. 14 (2002) 431-443
5. Vennerstrom J.L., Makler M.T., Angerhofer C.K., and Williams J.A. Antimalarial dyes revisited: xanthenes, azines, oxazines, and thiazines. Antimicrob. Agents Chemother. 39 (1995) 2671-2677
6. Wainwright M., and Amaral L. The phenothiazinium chromophore and the evolution of antimalarial drugs. Trop. Med. Int. Health 10 (2005) 501-511
7. Schirmer R.H., Coulibaly B., Stich A., et al. Methylene blue as an antimalarial agent. Redox Rep. 8 (2003) 272-276
8. Csaba G., and Korosi J. A new antitumour agent: phenazathionium-mustard salt. Neoplasma 15 (1968) 443-445
9. Wainwright M. Phenothiazinium photosensitisers V. Photobactericidal activities of chromophore-methylated phenothiazinium salts. Dyes Pigments 73 (2006) 7-12
10. Wagner S.J., Skripchenko A., Robinette D., Foley J.W., and Cincotta L. Factors affecting virus photoinactivation by a series of phenothiazine dyes. Photochem. Photobiol. 67 (1998) 343-349
11. Wainwright M., and Giddens R.M. Phenothiazinium photosensitisers: choices in synthesis and application. Dyes Pigments 57 (2003) 245-257
12. Foley J.W., Cincotta L., and Cincotta A.H. Structure and properties of novel benzo[a]phenoxazinium photochemotherapeutic agents. Proc. SPIE 847 (1987) 90-95
13. Wainwright M. Photodynamic antimicrobial chemotherapy (PACT). J. Antimicrob. Chemother. 42 (1998) 13-28
14. Wainwright M., Phoenix D.A., Marland J., Wareing D.R.A., and Bolton F.J. A study of photobactericidal activity in the phenothiazinium series. FEMS Immunol. Med. Microbiol. 19 (1997) 75-80
15. Wainwright M. The use of dyes in modern biomedicine. Biotech. Histochem. 78 (2003) 147-155
16. O'Neill J., Wilson M., and Wainwright M. Comparative antistreptococcal activity of a range of photobactericidal agents. J. Chemother. 15 (2003) 329-334
17. Segalla A., Borsarelli C.D., Braslavsky S.E., et al. Photophysical, photochemical and antibacterial photosensitizing properties of a novel octationic Zn(II)-phtalocyanine. Photochem. Photobiol. Sci. 1 (2002) 641-648
18. Minnock A., Vernon D.I., Schofield J., Griffiths J., Parish J.H., and Brown S.B. Photoinactivation of bacteria. Use of a cationic water-soluble zinc phthalocyanine to photoinactivate both Gram-negative and Gram-positive bacteria. J. Photochem. Photobiol., B: Biol. 32 (1996) 159-164
19. Soukos N.S., Ximenez-Fyvie L.A., Hamblin M.R., Socransky S.S., and Hasan T. Targeted antibacterial photochemotherapy. Antimicrob. Agents Chemother. 42 (1998) 2595-2601
20. Tuite E.M., and Kelly J.M. New trends in photobiology: photochemical interactions of methylene blue and analogues with DNA and other biological substrates. J. Photochem. Photobiol., B: Biol. 21 (1993) 103-124
21. Corash L. Virus inactivation in cellular components. Vox Sang. 70 (1996) 9-16
22. Wilson M., and Mia N. Effect of environmental factors on the lethal photosensitization of Candida albicans in vitro. Lasers Med. Sci. 9 (1994) 105-109
23. de Souza S.C., Junqueira J.C., Balducci I., Koga-Ito C.Y., Munin E., and Jorge A.O.C. Photosensitization of different Candida species by low power laser light. J. Photochem. Photobiol., B: Biol. 83 (2006) 34-38
24. Thurston J.P. The chemotherapy of Plasmodium berghei. I. Resistance to drugs. Parasitology 43 (1953) 246-252
25. Boda C., Enanga B., Courtioux B., Breton J.C., and Bouteille B. Trypanocidal activity of methylene blue evidence for in vitro efficacy and in vivo failure. Chemotherapy 52 (2006) 16-19
26. Cincotta L., Foley J.W., and Cincotta A.H. Novel phenothiazinium photosensitizers for photodynamic therapy. SPIE Adv. Photochemother. 997 (1988) 145-153
27. Cincotta L., Foley J.W., and Cincotta A.H. Novel red absorbing benzo[a]phenoxazinium and benzo[a]phenothiazinium photosensitizers: in vitro evaluation. Photochem. Photobiol. 46 (1987) 751-758
28. Wainwright M. Methylene blue derivatives - suitable photoantimicrobials for blood product disinfection?. Int. J. Antimicrob. Agents 16 (2000) 381-394
29. Bachmann B., Knuver-Hopf J., Lambrecht B., and Mohr H. Target structures for HIV-1 inactivation by methylene blue and light. J. Med. Virol. 47 (1995) 172-178
30. Wainwright M., Phoenix D.A., Rice L., Burrow S.M., and Waring J.J. Increased cytotoxicity and phototoxicity in the methylene blue series via chromophore methylation. J. Photochem. Photobiol., B: Biol. 40 (1997) 233-239
31. Dodd R.Y. The risk of transfusion-transmitted infection. New Engl. J. Med. 327 (1992) 419-421
32. Blajchman A.J., Goldman M., and Baeza F. Improving the bacteriological safety of platelet transfusions. Tranfusion Med. Rev. 18 (2004) 11-24
33. Lambrecht B., Mohr H., Knuever-Hopf J., and Schmitt H. Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light. Vox. Sang. 60 (1991) 207-213
34. Snyder E., McCullough J., Slichter S.J., Strauss R.G., Lopez-Plaza I., Lin J.-S., Corash L., and Conlan M.G. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial. Transfusion 45 (2005) 1864-1875
35. Ruane P.H., Edrich R., Gampp D., Keil S.D., Leonard R.L., and Goodrich R.P. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 44 (2004) 877-885
36. Williamson L.M., Cardigan R.A., and Prowse C.V. Methylene blue-treated fresh-frozen plasma: what is its contribution to blood safety?. Transfusion 43 (2003) 1322-1329
37. T. Verpoort, S. Chollet, C. Heron, et al., Filtration of Methylene Blue and photoproducts after photodynamic treatment of plasma using Blueflex, ISBT-Congress, Istanbul, 2003; Abstr. P246.
38. Tissot J.D., Hochstrasser D.F., Schneider B., Morgenthaler J.J., and Schneider P. No evidence for protein modification in fresh-frozen plasma after photochemical treatment: an analysis by high-resolution two-dimensional electropheresis. Brit. J. Hematol. 86 (1994) 143-149
39. Pohler P., Walker W.H., Reichenberg S., Mohr H., Gravemann U., and Müller T.H. Methylene blue treated plasma: pharmacokinetic and toxicological profile of MB and photoproducts. Vox. Sang. 87 (2004) 93 Abstr. A 10.2
40. Pathogen inactivation of Labile Blood Products. Council of Europe Publishing, February 2001; ISBN: 92-871-4560-1, Strasbourg, France.
41. Mohr H., and Redecker-Klein A. Inactivation of pathogens in platelet concentrates by using a two-step procedure. Vox Sang. 84 (2002) 96-104
42. Karnofsky J.R. Quenching of singlet oxygen by human plasma. Photochem. Photobiol. 51 (1990) 299-303
43. T'ung T. Photodynamic action of methylene blue on bacteria. Proc. Soc. Exp. Biol. Med. 33 (1935) 328-330
44. T'ung T., and Zia S.H. Photodynamic action of various dyes on bacteria. Proc. Soc. Exp. Biol. Med. 36 (1937) 326-330
45. Wilson M., Dobson J., and Harvey W. Sensitization of oral bacteria to killing by low-power laser radiation. Curr. Microbiol. 25 (1992) 77-81
46. Sarkar S., and Wilson M. Lethal photosensitization of bacteria in subgingival plaque from patient with chronic perodontitis. J. Periodont. Res. 28 (1993) 204-210
47. Wainwright M., Phoenix D.A., Wareing D.R.A., and Smillie T.E. Photobactericidal activity of phenothiaziniums against Yersinia enterocolitica. J. Chemother. 13 (2001) 503-509
48. Wainwright M. The emerging chemistry of blood disinfection. Chem. Soc. Rev. 31 (2002) 126-136
49. Wainwright M., Phoenix D.A., Laycock S.L., Wareing D.R.A., and Wright P.A. Photobacterial activity of phenothiazinum dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol. Lett. 160 (1998) 177-181
50. Wilson M., Sarkar S., and Bulman J.S. Effect of blood on lethal photosensitization of bacteria in subgingival plaque from patients with chronic periodontitis. Lasers Med. Sci. 8 (1993) 297-303
51. Wilson M., and Pratten J. Lethal photosensitization of Staphylococcus aureus in vitro: effect of growth phase, serum and pre-irradiation time. Lasers Surg. Med. 16 (1995) 272-276
52. Gulliksson H., Larsson S., Kumlien G., and Shanwell A. Storage of platelets in additive solutions: effects of phosphate. Vox Sang. 78 (2000) 176-184
53. Murphy S. The efficacy of synthetic media in the storage of human platelets for transfusion. Transfus. Med. Rev. 13 (1999) 153-163
54. Dzik W. Use of leukodepletion filters for the removal of bacteria. Immunol. Invest. 24 (1995) 95-115
55. Eernisse J.G., and Brand A. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components. Exp. Hematol. 9 (1981) 77-83
56. Skripchenko A.A., and Wagner S.J. Inactivation of WBCs in RBC suspensions by photoactive phenothiazine dyes: comparison of dimethylmethylene blue and MB. Transfusion 40 (2000) 968-975
57. Taylor K.B., and Jeffree G.M. A new basic metachromatic dye, 1:9-dimethyl methylene blue. Histochem. J. 1 (1969) 199-204
58. Wainwright M. Pathogen inactivation in blood products. Curr. Med. Chem. 9 (2002) 127-143
59. Rudensky B. Comparison of a semi-automated new Coulter methylene blue method with fluorescence flow cytometry in reticulocyte counting. Scand. J. Clin. Lab. Invest. 57 (1997) 291-296
60. Inoue T., and Tatsumi N. Evaluation of erythropoiesis by new methylene blue staining to establish reticulocyte maturity in bone marrow aspirates and peripheral blood. Acta. Cytol. 35 (1991) 479-480
61. Greenwalt T.J., Steane E.A., Lau F.O., and Sweeney-Hammond K. Aging of the human erythrocyte. Prog. Clin. Biol. Res. 43 (1980) 195-212
62. Gliesing M., and Halbhuber K.J. Topo-optical studies of gradually disintegrated erythrocyte membrane derivates: different kinds of ghosts. Acta. Histochem. 86 (1989) 117-121
63. Makovitzky J., Bozsoky S., and Laszlo E. Topo-optical reactions of the human blood platelet membrane. Histochemistry 79 (1983) 281-287
64. Marshall P.N., Bentley S.A., and Lewis S.M. Purified azure B as a reticulocyte stain. J. Clin. Pathol. 29 (1976) 1060-1063
65. Papin J.F., Floyd R.A., and Dittmer D.P. Methylene blue photoinactivation abolishes West Nile virus infectivity in vivo. Antiviral Res. 68 (2005) 84-87
66. Adamcikova L., Paylikova K., and Sevcik P. The decay of methylene blue in alkaline solution. React. Kin. Catal. Lett. 69 (2000) 91-94
67. Skripchenko A., Robinette D., and Wagner S.J. Comparison of methylene blue and methylene violet for photoinactivation of intracellular and extracellular virus in red cell suspensions. Photochem. Photobiol. 65 (1997) 451-455
68. Houghtaling M.A., Perera R., Owen K.E., Wagner S., Kuhn R.J., and Morrison H. Photobiological properties of positively charged methylene violet analogs. Photochem. Photobiol. 71 (2000) 20-28
69. Smelt D., Repanovici P., Pascaru A., and Portocala R. Photodynamic effect of toluidine blue on MM virus. Rev. Roum. Med. Virol. 27 (1976) 203-207
70. Morrison H., Mohammad T., and Kurukulasuriya R. Photobiological properties of methylene violet. Photochem. Photobiol. 66 (1997) 245-252
71. Eveland L.K., and Allen E.G. Nile blue stain: Plasmodium berghei and uninfected erythrocytes. Trans. Roy. Soc. Trop. Med. Hyg. 66 (1972) 512-513
72. Photo-inactivation of cancer cells, US Patent 4962197, 09.10.90.
73. Lin C.W., Shulok J.R., Kirley S.D., et al. Photodynamic destruction of lysosomes mediated by Nile blue photosensitizers. Photochem. Photobiol. 58 (1993) 81-91
74. Crossley M.L., Dreisbach P.F., Hofmann C.M., and Parker R.P. Chemotherapeutic dyes. I. 5-Aralkylamino-9-alkylaminobenzo[a]phenoxazines. J. Am. Chem. Soc. 74 (1952) 573-578
75. Crossley M.L., Turner R.J., Hofmann C.M., Dreisbach P.F., and Parker R.P. Chemotherapeutic dyes. II. 5-Arylamino-9-dialkylaminobenzo[a]phenoxazines. J. Am. Chem. Soc. 74 (1952) 578-584
76. Crossley M.L., Hofmann C.M., and Dreisbach P.F. Chemotherapeutic dyes. III. 5-Heterocyclicamino-9-dialkylaminobenzo[a]phenoxazines. J. Am. Chem. Soc. 74 (1952) 584-586
77. Clapp R.C., Clark J.H., English J.P., Fellows C.E., Grotz R.E., and Shepherd R.G. Chemotherapeutic dyes. IV. Phenoxazines and benzo[a]phenoxazines. J. Am. Chem. Soc. 74 (1952) 1989-1993
78. Clapp R.C., English J.P., Fellows C.E., Forsythe J., Grotz R.E., and Shepherd R.G. Chemotherapeutic dyes. V. Benzo[a]phenothiazines and benzo[a]phenazines. J. Am. Chem. Soc. 74 (1952) 1994-1996
79. Wainwright M., Grice N.J., and Pye L.E.C. Phenothiazine Photosensitisers. Part II. 3,7-Bis(arylamino)phenothiazines. Dyes Pigments 42 (1999) 45-51
80. M. Wainwright, Publication in preparation.